Compass Pathways Analyst Price Targets

Wall Street analyst price targets and consensus rating for Compass Pathways (CMPS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

13Buy

Consensus RatingBuy# Analysts13Avg. Consensus PT$22Upside to Avg. PT+55.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$70→$65
Aug 6, 2026	Morgan Stanley	Judah Frommer	PT Raise	Overweight	$17→$18
Aug 6, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$22→$21
Aug 6, 2026	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$17→$22
Jul 27, 2026	Wells Fargo	Benjamin Burnett	Initiate	Equal-Weight	$13
Jul 8, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$70
Jul 8, 2026	Evercore ISI Group	Gavin Clark-Gartner	Upgrade	In-Line→Outperform	$8→$21
Jul 8, 2026	Stifel	Paul Matteis	PT Raise	Buy	$14→$21
Jul 7, 2026	Morgan Stanley	Judah Frommer	Maintained	Overweight	$17
Jul 7, 2026	Oppenheimer	Francois Brisebois	Maintained	Outperform	$20
Jul 7, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$14→$25
Jun 26, 2026	Canaccord Genuity	Sumant Kulkarni	PT Raise	Buy	$18→$20
May 15, 2026	Maxim Group	Jason McCarthy	PT Raise	Buy	$12→$20
May 14, 2026	Morgan Stanley	Judah Frommer	PT Raise	Overweight	$16→$17
May 14, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$21→$22
May 13, 2026	BTIG	Thomas Shrader	Maintained	Buy	$14
May 4, 2026	Jefferies	Andrew Tsai	Initiate	Buy	$18
Apr 28, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$70
Apr 24, 2026	B. Riley Securities	Madison El-Saadi	Initiate	Buy	$17
Apr 20, 2026	BTIG	Thomas Shrader	Maintained	Buy	$14

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $70 to $65.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $17 to $18.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21

RBC Capital analyst Leonid Timashev maintains Compass Pathways (NASDAQ:CMPS) with a Outperform and lowers the price target from $22 to $21.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22

B. Riley Securities analyst Madison El-Saadi maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $17 to $22.

Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13

Wells Fargo analyst Benjamin Burnett initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Equal-Weight rating and announces Price Target of $13.

Benzinga Newsdesk

Why Is Neuronetics Stock Soaring Monday?

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. Read the details here.

Vandana Singh

Compass Pathways PLC

Compass Pathways Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

PRO
Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

PRO
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21

PRO
B. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22

PRO
Wells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13

Why Is Neuronetics Stock Soaring Monday?

People Also Watch

People Also Watch

Compass Pathways PLC

Compass Pathways Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

PROMorgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

PRORBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21

PROB. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22

PROWells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13

Why Is Neuronetics Stock Soaring Monday?

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

PRO
Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

PRO
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21

PRO
B. Riley Securities Maintains Buy on Compass Pathways, Raises Price Target to $22

PRO
Wells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13